AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Evogene Ltd. Capital/Financing Update 2025

Mar 28, 2025

6785_rns_2025-03-28_b0feb1ef-1770-4f0b-a81a-587fa8c67d23.htm

Capital/Financing Update

Opens in your device viewer

_________ false


�� "�	2 381
EVOGENE LTD
Corporation no: 512838723	14299
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	28/03/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-02-021831	Time of broadcast: 13:47 13:47

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.


Attached hereto is a report on	POST-EFFECTIVE AMENDMENT NO.1 TO FORM F-1

F1_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 06/08/2024
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected] Company site: www.evogene.com

Previous names of reporting entity:

Name of the Signatory: Deutsch Nitsan Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7638517 Telephone: 08-9311900 Facsimile: 08-9466724 E-mail: [email protected] 1